Evidence map›Paper›PMID 39558138›Full record

ArticleBone marrow transplantation2025

Belumosudil combination therapy for chronic graft-versus-host-disease in real-world clinical practice.

Michelle M Chin, John S Tamaresis, Laura J Johnston, Robert Lowsky, Everett Meyer, Lori Muffly, Parveen Shiraz, Matthew J Frank, Andrew R Rezvani, Sushma Bharadwaj and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Advances in treatment of chronic graft-versus-host disease.International journal of hematology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Michelle M ChinUniversity of Central Florida College of Medicine, Orlando, FL, USA.
John S TamaresisDepartment of Biomedical Data Science, Stanford University, Stanford, CA, USA.
Laura J JohnstonDivision of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA.
Robert LowskyDivision of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA.
Everett MeyerDivision of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA.
Lori MufflyDivision of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA.ORCID http://orcid.org/0000-0002-9887-6136
Parveen ShirazDivision of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA.ORCID http://orcid.org/0000-0002-6721-0358
Matthew J FrankDivision of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA.
Andrew R RezvaniDivision of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA.
Sushma BharadwajDivision of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA.
Wen-Kai WengDivision of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA.
Judith A ShizuruDivision of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA.ORCID http://orcid.org/0000-0003-3246-4726
Sally AraiDivision of BMT and Cellular Therapy, Stanford University, Palo Alto, CA, USA. sarai1@stanford.edu.ORCID http://orcid.org/0000-0003-1993-4172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39558138
PMCPMC11893440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.